Sensus Healthcare to Participate in Two Upcoming Investor Conferences
BOCA RATON, Fla., Aug. 27, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will participate at two investor conferences in September 2018, as follows: Annual B. […]
What You Should Know About Your Family’s History of Skin Cancer
Do you know your family’s history of skin cancer? If one or more of your parents, siblings, or children develop skin cancer, you have a higher risk of developing skin cancer than a person with no family history of the disease. In fact, according to Sun & Skin News, a Skin Cancer Foundation publication, about […]
Making Sense of the Link Between Skin Color and Skin Cancer
While those with lighter skin tones are generally the most at risk for skin cancer, anyone with any skin color can get skin cancer. Unfortunately, many patients are under the impression that those with darker skin are not at risk for skin cancer. “People who have darker skin tones often believe that they’re not at […]
Inc: 19 Ideas on How to Push Yourself to the Next Level
Inc. recently sat down with 19 successful founders and executives to discuss how they push themselves to the next level. When asked about his support system, CEO of Sensus Healthcare, Joe Sardano, said, “One maxim our team hangs onto is, ‘Who packs your parachute?’ This saying comes from an old story originated by a U.S. Navy […]
OWM Industry Spotlight: Joe Sardano
CEO, Chairman and Co-Founder of Sensus Healthcare, Joe Sardano, was recently interviewed for a feature in AAWC‘s research journal, Ostomy Wound Management (OWM). Read the full interview here.
Fall Clinical Dermatology Conference
Join Sensus Healthcare at the Fall Clinical Dermatology Conference in Las Vegas, NV October 18th – 21st, 2018. For tickets and more information click here.
Sensus Healthcare Second Quarter Financial Results Feature Continued Strong Revenue Growth
Ships 21 systems including 12 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 2, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three […]
Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radio Therapy for Treating Non-Melanoma Skin Cancer and Keloids
SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as Well as Core System Enhancements BOCA RATON, Fla., Aug. 2, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy […]
5CC in Barcelona
Join Sensus Healthcare at the 5-Continent-Congress (5CC) in Barcelona, Spain August 30th – September 2nd, 2018. For tickets and more information click here.
